Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x

HEALTHPEAK Aktie

 >HEALTHPEAK Aktienkurs 
15.5 EUR    +2.0%    (Tradegate)
Ask: 15.6 EUR / 220 Stück
Bid: 15.5 EUR / 220 Stück
Tagesumsatz: 981 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
HEALTHPEAK Aktie über LYNX handeln
>HEALTHPEAK Performance
1 Woche: -3,7%
1 Monat: -5,2%
3 Monate: +1,3%
6 Monate: -0,6%
1 Jahr: -25,1%
laufendes Jahr: -18,8%
>HEALTHPEAK Aktie
Name:  HEALTHPEAK PROPERTIES
Land:  USA
Sektor:  Immobilien
ISIN/ Wkn:  US42250P1030 / A2N5NP
Symbol/ Ticker:  HC5 (Frankfurt) / DOC (NYSE)
Kürzel:  FRA:HC5, ETR:HC5, HC5:GR, NYSE:DOC
Index:  S&P500
Webseite:  https://www.healthpeak.co..
Profil:  Healthpeak Properties Inc. is a prominent real est..
>Volltext..
Marktkapitalisierung:  11045.13 Mio. EUR
Unternehmenswert:  19538.64 Mio. EUR
Umsatz:  2427.77 Mio. EUR
EBITDA:  1381.2 Mio. EUR
Nettogewinn:  -33.75 Mio. EUR
Gewinn je Aktie:  -0.05 EUR
Schulden:  8175.65 Mio. EUR
Liquide Mittel:  138.44 Mio. EUR
Operativer Cashflow:  1098.01 Mio. EUR
Bargeldquote:  12
Umsatzwachstum:  3.98%
Gewinnwachstum:  -111.96%
Dividende je Aktie:  1.13 EUR
Dividendenrendite:  6.77%
Dividendenschätzung:  6.8%
Div. Historie:  17.10.25 - 0.08723286€
19.09.25 - 0.08723286€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  HEALTHPEAK
Letzte Datenerhebung:  02.11.25
>HEALTHPEAK Kennzahlen
Aktien/ Unternehmen:
Aktien: 694.95 Mio. St.
Frei handelbar: 99.68%
Rückkaufquote: 0.76%
Mitarbeiter: 387
Umsatz/Mitarb.: 6.05 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 14.3%
Bewertung:
KGV: -
KGV lG: 109.65
KUV: 4.36
KBV: 1.67
PEG-Ratio: -
EV/EBITDA: 14.15
Rentabilität:
Bruttomarge: 21.83%
Gewinnmarge: -1.39%
Operative Marge: 18.65%
Managementeffizenz:
Gesamtkaprendite: -0.2%
Eigenkaprendite: -0.48%
>HEALTHPEAK Peer Group

Es sind 187 Aktien bekannt.
 
24.10.25 - 21:15
Healthpeak Q3 FFO Beats Estimates, Same-Store NOI Rises Y/Y (Zacks)
 
DOC's third-quarter results reflect the continued strong performance of its high-quality outpatient medical and CCRC portfolios....
24.10.25 - 18:54
Healthpeak signals $1B asset recycling window as lab pipeline doubles and tech investments drive cost savings (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
24.10.25 - 17:36
Earnings Call: Healthpeak Properties verfehlt Gewinnprognose für Q3 2025 deutlich (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
24.10.25 - 01:45
Healthpeak (DOC) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
 
Although the revenue and EPS for Healthpeak (DOC) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers....
23.10.25 - 22:42
Healthpeak Properties Q3 profit bolstered by faster outpatient medical demand (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
23.10.25 - 22:21
Healthpeak Properties Provides Strategic Initiatives Update and Reports Third Quarter 2025 Results (Business Wire)
 
DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, today provided a strategic initiatives update and announced results for the quarter ended September 30, 2025. STRATEGIC INITIATIVES AND COMMENTARY Outpatient medical demand is growing faster than new supply, which, combined with our leading platform and deep health system relationships, is driving strong cash re-leasing spreads including +5.4% in the quarter, higher annual escalators including +3% on leases signed in the quarter versus +2.7% on the existing portfolio, and low tenant improvement outlays which represented less than 5% of rent on renewals signed in the quarter. Total occupancy was up +10 basis points sequentially. Private market values for outpatient medical buildings have strengthened as inflation and interest rates have declined. We are in various stages of negotiation on opportunistic sales and recapitalizations that could generat...
21.10.25 - 19:00
What′s in the Cards for Healthpeak Properties This Earnings Season? (Zacks)
 
DOC's Q3 earnings are likely to be hurt by lower revenues and higher interest expenses amid an aging population....
21.10.25 - 16:45
Wall Street′s Insights Into Key Metrics Ahead of Healthpeak (DOC) Q3 Earnings (Zacks)
 
Beyond analysts' top-and-bottom-line estimates for Healthpeak (DOC), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2025....
16.10.25 - 23:48
XFRA: DIVIDEND/INTEREST INFORMATION - 17.10.2025 - US42250P1030 (XETRA)
 
Das Instrument HC5 US42250P1030 HEALTHPEAK PROP.INC. DL 1 EQUITY wird ex Dividende/Zinsen gehandelt am 17.10.2025 The instrument HC5 US42250P1030 HEALTHPEAK PROP.INC. DL 1 EQUITY has its ex-dividend/interest day on 17.10.2025...
15.10.25 - 23:51
XFRA: DIVIDEND/INTEREST INFORMATION - 17.10.2025 - US42250P1030 (XETRA)
 
Das Instrument HC5 US42250P1030 HEALTHPEAK PROP.INC. DL 1 EQUITY wird cum Dividende/Zinsen gehandelt am 16.10.2025 und ex Dividende/Zinsen am 17.10.2025 The instrument HC5 US42250P1030 HEALTHPEAK PROP.INC. DL 1 EQUITY has its pre-dividend/interest day on 16.10.2025 and its ex-dividend/interest day on 17.10.2025...
07.10.25 - 08:24
What to Expect From Healthpeak Properties′ Next Quarterly Earnings Report (Barchart)
 
Healthpeak Properties is gearing up to announce its third-quarter results later this month, and analysts expect its funds from operations to remain flat....
06.10.25 - 22:33
Healthpeak Properties declares $0.1017 dividend (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
06.10.25 - 22:18
Healthpeak Properties Declares Monthly Common Stock Cash Dividends for the Fourth Quarter of 2025 (Business Wire)
 
DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, announced that on October 6, 2025, its Board of Directors declared a monthly common stock cash dividend of $0.10167 per share for the fourth quarter of 2025, payable on the payment dates set forth in the table below to stockholders of record as of the close of business on the corresponding record date in the table below. The monthly dividend reflects an annualized dividend amount of $1.22 per share of common stock. Record Date Payment Date Amount October 17, 2025 October 30, 2025 $0.10167 per common share November 14, 2025 November 26, 2025 $0.10167 per common share December 19, 2025 December 30, 2025 $0.10167 per common share ABOUT HEALTHPEAK PROPERTIES Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery...
03.10.25 - 12:48
Is AGNC Investment a Better Dividend Stock Than Healthpeak Properties? (Fool)
 
These two high-yielding monthly dividend stocks go head-to-head....
25.09.25 - 22:21
Healthpeak Properties Announces Third Quarter 2025 Earnings Release Date and Conference Call Details (Business Wire)
 
DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, is scheduled to report third quarter 2025 financial results after the close of trading on the New York Stock Exchange on Thursday, October 23, 2025. Healthpeak will host a conference call and webcast on Friday, October 24, 2025, at 8:00 a.m. Mountain Time (10:00 a.m. Eastern Time) to review its financial performance and operating results. The conference call can be accessed in the following ways: Healthpeak's website: https://ir.healthpeak.com/news-events Webcast: https://events.q4inc.com/attendee/161073286. Joining via webcast is recommended for those who will not be asking questions. Telephone: The participant dial-in number is (800) 715-9871. An archive of the webcast will be available on Healthpeak's website through October 23, 2026, and a telephonic replay can be accessed through October 31, 2025, by dialing (800) 770-2030 and entering conf...
23.09.25 - 10:00
Is Healthpeak Properties Stock Underperforming the Nasdaq? (Barchart)
 
Although Healthpeak Properties has lagged the Nasdaq Composite recently, analysts maintain a cautiously positive outlook on the stock's potential....
18.09.25 - 23:42
XFRA: DIVIDEND/INTEREST INFORMATION - 19.09.2025 - US42250P1030 (XETRA)
 
Das Instrument HC5 US42250P1030 HEALTHPEAK PROP.INC. DL 1 EQUITY wird ex Dividende/Zinsen gehandelt am 19.09.2025 The instrument HC5 US42250P1030 HEALTHPEAK PROP.INC. DL 1 EQUITY has its ex-dividend/interest day on 19.09.2025...
15.09.25 - 14:36
Raymond James upgrades Healthpeak, downgrades Healthcare Realty to Underperform (Investing.com)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
27.08.25 - 12:03
Healthpeak Strengthens Life Science Leadership with Addition of Denis Sullivan as Managing Director of Lab Investments & San Diego Market Lead and Promotion of Mike Dorris as Head of West Coast Development & Construction (Business Wire)
 
DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (“Healthpeak” or the “Company”) (NYSE: DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, announced that Denis Sullivan is joining Healthpeak as Managing Director of Lab Investments & San Diego Market Lead and Mike Dorris has been promoted to Head of West Coast Development & Construction. These moves underscore the Company's conviction in the life science sector and position Healthpeak to capture investment and leasing opportunities as the market recovers. Mr. Sullivan brings two decades of life science real estate leadership, with expertise spanning investments, operations, and capital strategy. He previously spent more than 14 years at BioMed Realty, ultimately serving as Chief Investment Officer and Chief Financial Officer, where he helped guide the company through significant growth. More recently, he was a Managing Partner and Co-Founder of Foundation Capital Ventures, where he helped devel...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Wer heilt, hat recht. - Hippokrates
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!